PLEASANTON, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) ProSomnus, Inc. (NASDAQ:OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea ("OSA"), today announced that their precision sleep apnea
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month. The updated data indicate the FLOSAT study is on track to achieve all endpoints.